# FDA Inspection 814842 - Braintree, A part of SEBELA Pharmaceuticals - January 14, 2013

Source: https://www.globalkeysolutions.net/records/fda_inspections/braintree-a-part-of-sebela-pharmaceuticals/fe3f162e-f53a-4d65-a540-7b3c69967bc8/
Source feed: FDA_Inspections

> FDA Inspection 814842 for Braintree, A part of SEBELA Pharmaceuticals on January 14, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 814842
- Company Name: Braintree, A part of SEBELA Pharmaceuticals
- Inspection Date: 2013-01-14
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1261728 - 2025-03-07](https://www.globalkeysolutions.net/api/records/fda_inspections/braintree-a-part-of-sebela-pharmaceuticals/4b903c68-595f-4b48-a387-1c742007f850/)
- [FDA Inspection 1261728 - 2025-03-07](https://www.globalkeysolutions.net/api/records/fda_inspections/braintree-a-part-of-sebela-pharmaceuticals/2f230059-8323-442e-8b68-dd71d065676a/)
- [FDA Inspection 1042622 - 2018-02-28](https://www.globalkeysolutions.net/api/records/fda_inspections/braintree-a-part-of-sebela-pharmaceuticals/717fe323-8916-49e3-b346-16040875b8a5/)
- [FDA Inspection 858979 - 2013-12-13](https://www.globalkeysolutions.net/api/records/fda_inspections/braintree-a-part-of-sebela-pharmaceuticals/c3a1df7e-8ea7-46ac-bef1-11ec0e804d15/)
- [FDA Inspection 707123 - 2011-01-21](https://www.globalkeysolutions.net/api/records/fda_inspections/braintree-a-part-of-sebela-pharmaceuticals/2980d372-45f6-4f29-bbd3-a2e16a160b75/)

Company: https://www.globalkeysolutions.net/companies/braintree-a-part-of-sebela-pharmaceuticals/e32fa961-98ff-4606-8883-8c382bf240e2

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c